￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Rubicatin/Rubitidine Price Analysis and Purchasing Channels: Latest Trends in 2025

2026-02-01 22:25:32

Check Details
How to use and dose Glasdegib

2026-02-01 22:25:32

Check Details
What diseases does Pirfenidone/Axri treat? Analysis of indications, clinical efficacy and applicable groups

2026-02-01 22:25:32

Check Details
Canafenib combined with cetuximab in the treatment of BRAF V600E-mutant mCRC

2026-02-01 22:25:32

Check Details
Is Sotolaxib included in medical insurance? Reimbursement conditions and scope of application

2026-02-01 22:25:32

Check Details
Is Adagrasib covered by medical insurance? Latest reimbursement policies and patient benefits

2026-02-01 22:25:32

Check Details
What are the medical insurance reimbursement conditions for afatinib? Which patients can benefit from

2026-02-01 22:25:32

Check Details
Detailed explanation of the functions and efficacy of Glasdegib

2026-02-01 22:25:32

Check Details
Is Acemini on Medicare? Interpretation of reimbursement conditions and latest policies

2026-02-01 22:25:32

Check Details
What reactions will occur after discontinuing ritexitinib? Discontinuation Risks and Precautions

2026-02-01 22:25:32

Check Details
When will sparsentan/sparsentan be available? Domestic and overseas listing time and approval progress tracking

2026-02-01 22:25:32

Check Details
What are the side effects of Ixazomib/Enleri? How to deal with it scientifically?

2026-02-01 22:25:32

Check Details
Category
相关知识